We are glad to report that in a recently published EMBO Journal paper “Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies” (https://doi.org/10.15252/embj.2021107985) the authors suggest that a Trimerbody against the receptor-binding domain (RBD) of the […]
June 7, 2021 MarketsandMarkets Conferences Doctor in Immunology from the Autonomous University of Madrid (Spain), extensive international career in the biopharmaceutical industry at Astellas Inc. and Bristol-Myers Squibb Co. (USA). Experienced R&D leader in immune-oncology (IO). Previously, participated […]
El director de la unidad de inmunoterapia del cáncer del Instituto de Investigación del Hospital 12 de Octubre, Luis Álvarez-Vallina, ha explicado el diseño de un nuevo anticuerpo que potencia la respuesta del sistema inmunitario frente a […]
Anglonordic is a great event to meet quality investors and companies – it is very well run and given the invitation only status it is well attended with quality investors and companies. This year we’re excited since […]
Clave Capital, through the fund Navarra Tech Transfer, consolidates with this new operation its commitment in the field of human health, in this case, together with Sodena and Capital Cell. https://capital-riesgo.es/es/articles/clave-invierte-en-leadartis-en-una-ronda-de-financiaci-n-de-m-s-de-1-600-000/
The entry of funds into leadartis’ shareholding is part of a round of financing closed by the company in recent times. «An action that has endowed it with 1.6 million euros that will advance the development of […]
https://clincancerres.aacrjournals.org/ Although systemic administration of anti-4-1BB-agonistic IgGs, have shown promise in early clinical studies have not completed clinical development due to their severe hepatotoxicity. Here we demonstrate that a humanized EGFR-specific 4-1BB-agonistic trimerbody exhibits potent anti-tumor activity […]
Leadartis reaches a major milestone with the demonstration of absence of toxicity of its EGFR-targeted 4-1BB-agonistic bispecific Trimerbody which does not Induce Hepatotoxicity in transgenic mice with liver expression of human EGFR (https://www.frontiersin.org/articles/10.3389/fimmu.2020.614363/full). These data support the […]
https://www.expansion.com/expansion-empleo/emprendedores/2020/11/09/5fa96073468aebc1148b4651.html
We are pleased to inform you that the investment round has been successfully closed, raising a total of € 1,250,000 euros, equivalent to 125% of the published goal of 1,000,000 euros. https://capitalcell.es/campaign/leadartis/. We will provide you with additional […]